Illumina Inc

Healthcare · Diagnostics & Research

255.40$ +3.2% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

Illumina Inc (ILMN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 6,644 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ILMN
Line item	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	34	133	122	122	99	95	101	301	988	1,377	1,430	1,839	2,196	2,566	3,019	3,337	3,688	4,281	5,257	6,959	7,316	7,585	15,217	12,252	10,111	6,303	6,644
Current Assets	33	129	96	73	40	84	80	194	563	865	982	1,258	1,545	1,787	1,618	1,890	2,097	2,318	2,980	4,490	4,451	4,483	2,713	3,561	2,609	2,746	3,289
Cash	21	116	4.2	2.0	12	55	51	38	175	327	145	249	303	434	712	636	769	735	1,225	1,144	2,042	1,810	1,232	2,011	1,048	1,127	1,418
Cash & Short-Term Investments	33	117	90	54	33	55	51	131	386	640	694	894	1,190	1,350	1,166	1,338	1,386	1,559	2,145	3,512	3,414	3,472	1,339	2,037	1,054	1,220	1,633
Receivables	0.3	0.3	1.3	3.7	4.8	12	18	40	83	133	158	166	174	215	239	289	386	381	411	514	573	487	664	688	752	751	854
Inventory	–	1.0	1.0	2.3	2.0	3.8	10	20	54	73	93	142	129	159	154	191	271	300	333	386	359	372	431	568	587	547	564
Property, Plant & Equipment	–	3.3	26	48	46	8.6	16	26	46	89	117	130	143	166	203	265	343	713	931	1,075	889	922	1,696	1,091	1,551	1,234	1,129
Goodwill	–	–	–	–	–	–	2.1	2.1	229	229	213	278	322	369	723	725	753	776	771	831	824	897	7,113	3,239	2,545	1,113	1,113
Intangible Assets	0.1	0.0	0.8	0.8	0.8	12	0.1	0.1	58	48	44	70	106	130	331	315	274	243	175	185	145	142	3,250	3,285	2,993	295	210
Total Liabilities	1.9	8.7	16	50	52	23	28	53	576	529	566	641	1,121	1,248	1,486	1,877	1,807	1,966	2,288	3,053	2,703	2,891	4,477	5,653	4,366	3,930	3,921
Current Liabilities	0.6	2.8	4.8	14	8.2	19	22	34	166	510	441	535	238	305	322	722	610	705	746	1,804	665	1,244	1,093	2,773	1,570	1,547	1,585
Short-Term Debt	0.0	0.3	0.3	0.7	0.6	0.1	0.1	0.1	0.0	400	290	312	37	37	29	304	75	1.3	10	1,107	45	562	71	1,324	86	578	577
Accounts Payable	0.3	0.7	2.0	1.8	7.6	2.7	7.4	9.9	24	29	53	67	50	66	74	83	139	138	160	184	149	192	332	293	245	221	240
Long-Term Debt	–	0.9	0.6	26	25	–	0.1	–	400	–	100	78	807	805	839	987	1,016	1,048	1,182	890	1,141	673	1,695	1,487	1,489	1,490	1,490
Shareholders' Equity	32	124	107	72	47	72	72	247	412	849	864	1,198	1,075	1,319	1,533	1,463	1,849	2,270	2,844	3,845	4,613	4,694	10,740	6,599	5,745	2,373	2,723
Retained Earnings	-6.7	-25	-50	-90	-117	-124	-145	-105	-383	-333	-280	-155	-69	83	208	561	1,023	1,485	2,256	3,083	4,067	4,723	5,485	1,142	-19	-1,242	-392
Shares Outstanding	2.8	56	59	62	64	72	80	98	108	134	137	143	139	134	140	149	149	148	148	149	149	148	151	157	158	159	156

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings